| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017548205 |
| P356 | DOI | 10.1007/BF00199838 |
| P698 | PubMed publication ID | 3815421 |
| P2093 | author name string | M P Fuggetta | |
| S D'Atri | |||
| E Bonmassar | |||
| M Roselli | |||
| L Tentori | |||
| A Aquino | |||
| L De Vecchis | |||
| P Ballatore | |||
| C Nunziata | |||
| P2860 | cites work | Properties and usefulness of the original K-562 human myelogenous leukemia cell line | Q28264733 |
| Interferon Therapy in Multiple Myeloma | Q33331397 | ||
| Alpha interferon for induction of remission in hairy-cell leukemia | Q33480781 | ||
| Recombinant interferon in advanced breast cancer | Q35991406 | ||
| How does interferon inhibit tumor growth? | Q38150583 | ||
| Interferon therapy in Hodgkin's disease. A case report | Q39242643 | ||
| Interferon therapy in myelomatosis | Q39533968 | ||
| Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity | Q39595504 | ||
| Cell-Mediated Immunity to Tumor Cells | Q39944336 | ||
| A Phase II trial of high-dose intravenous interferon alpha-2 in advanced colorectal cancer | Q40823158 | ||
| Lack of response in nine patients with breast cancer treated with fibroblast interferon | Q40831510 | ||
| Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma | Q40859477 | ||
| Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma | Q40959076 | ||
| Combined effects of BCG or Candida albicans (CA) with antitumor agents against a virus-induced lymphoma in mice | Q41156512 | ||
| Combined effects of natural resistance and chemotherapy against a murine lymphoma in lethally-irradiated mice. | Q54529676 | ||
| Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice. | Q54591297 | ||
| Comparison of effects of leukocyte and fibroblast interferon on immunological parameters in cancer patients | Q56967768 | ||
| Mechanism of the Antitumour Effect of Interferon in Mice | Q59078562 | ||
| A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion | Q61819334 | ||
| In-vitro testing of cyclophosphamide on tumors | Q67329040 | ||
| Kinetic analysis of target cell destruction by effector T cells. I. Delineation of parameters related to the frequency and lytic efficiency of killer cells | Q67528940 | ||
| Inhibition of spontaneous mammary carcinoma of mice by treatment with interferon and poly I:C | Q68625684 | ||
| Combined chemoimmunostimulation therapy against murine leukemia | Q69167141 | ||
| Lymphokine-activated killer cells: a new approach to immunotherapy of cancer | Q69873632 | ||
| Dose-response effects of 4-hydroperoxycyclophosphamide on human T and B cell function in vitro | Q69974896 | ||
| Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon | Q70921991 | ||
| Combined effects of antineoplastic agents and anti-lymphoma allograft reactions | Q71141809 | ||
| Influence of tumor-host differences at a single histocompatibility locus (H-1) on the antileukemic effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC 409962) | Q71579276 | ||
| Effect of human leukocyte interferon on the metastatic lung tumor of osteosarcoma. Case reports | Q72617964 | ||
| Natural killer cells | Q72637484 | ||
| Interferon therapy in multiple myeloma: Failure of human fibroblast interferon administration to affect the course of light chain disease | Q72656464 | ||
| Differential reactivity of mice to alloantigens associated with the D and K end of H-2: preliminary studies with bone marrow and lymphoma grafts | Q93710930 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 86-91 | |
| P577 | publication date | 1987-01-01 | |
| P1433 | published in | Cancer Immunology, Immunotherapy | Q5031409 |
| P1476 | title | Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy | |
| P478 | volume | 24 |
| Q68502600 | Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy |
| Q40743081 | Immuno-chemotherapy of advanced colorectal cancer with alpha-2a interferon and 5-fluorouracil. Immunopharmacological studies |
Search more.